Chemical Services Group, Inc./Royal Chemical Company
Warning LetterOpen
Mr. Matt Dailey
CEO & President
Chemical Services Group, Inc./Royal Chemical Company
8679 South Freeway Drive
Macedonia , OH 44056-1535
United States
matt.dailey@royalchemical.comFEI 2517008Issued Apr 5, 2023Division of Pharmaceutical Quality Operations I
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 2517008.
Violations5
Issue DateApr 5, 2023
Product TypeDrugs
StatusOpen
Letter Details
Firm
Chemical Services Group, Inc./Royal Chemical Company
Location
Mr. Matt Dailey
CEO & President
Chemical Services Group, Inc./Royal Chemical Company
8679 South Freeway Drive
Macedonia , OH 44056-1535
United States
matt.dailey@royalchemical.com
FEI Number
2517008
Country
United States
Issue Date
April 05, 2023
Issuing Office
Division of Pharmaceutical Quality Operations I
Product Type
Drugs
Status
Open
Summary
Chemical Services Group, Inc./Royal Chemical Company was cited for significant Current Good Manufacturing Practice (CGMP) violations in the production of over-the-counter hand sanitizer drug products at their Pennsylvania facility. The company failed to establish adequate written procedures for equipment cleaning and maintenance, and critically, manufactured pharmaceutical products on the same equipment used for non-pharmaceutical chemicals including industrial cleaners, polymers, and paint additives, creating unacceptable cross-contamination risks. Additionally, the firm left drug component and bulk drug product transfer pipes open to the outside environment without proper cleaning procedures or safeguards for external storage tanks. The company's response to the FDA's initial inspection findings was deemed inadequate for failing to provide sufficient detail or evidence of corrective actions necessary to achieve CGMP compliance.
Chemical Services Group, Inc./Royal Chemical Company FDA Warning Letter, April 5, 2023